Navigation Links
Health Robotics Announces Contract for its CytoCare(TM) and IV Station(TM) Robots With Arabian Health Care Supply Corporation

BOZEN, Italy, November 4 /PRNewswire/ -- Health-Robotics today announced that it has signed an exclusive 5-year strategic partnership with Arabian Health Care Supply Corporation (AHCSC-OLAYAN), the leading Medical Device, Pharmaceutical Automation and IV Solution provider within the Gulf Cooperation Council (GCC) countries. OLAYAN desires to safely, accurately, and cost-effectively automate the preparation of life-critical hazardous and non-hazardous IV Admixtures with Health Robotics' CytoCare(TM) and IV Station(TM) Robots. Under this strategic partnership, AHCSC-OLAYAN will take delivery of 32 CytoCare(TM) Robots and 175 IV Station(TM) Robots between now and December 31st 2013 for deployment at the Kingdom of Saudi Arabia, Kuwait, United Arab Emirates, Bahrain, Qatar, Oman, Yemen, Syria, Lebanon, Irak, Jordan, and Palestine.

"We are very pleased to have been chosen by Health Robotics as their GCC exclusive partner for these exciting new technologies. We are also proud to have been awarded the official tender process at King Faisal Specialist Hospital and Research Centre for both CytoCare(TM) and IV Station(TM) Robots, the latter in direct competition with IHS' RIVA Robot. Not only did Health Robotics amply demonstrated the proof that our customers and pharmacy experts demanded, but it did so during this official procurement process at much lesser expense to our customers than the IHS' RIVA Robot, once all the true costs of deployment were accurately verified by the Hospital's Steering Committee. In addition, having had many years' experience with Pyxis, I can honestly say that IV Station(TM) has the real potential to revolutionize Pharmacy Automation for IVs patient doses globally", stated Othman Abahussein, General Manager, AHCSC-Olayan.

Health-Robotics has developed and installed the world's first and only totally automated system for safe preparation of patient-specific hazardous IV Admixtures in Europe, the United States of America, Asia-Pacific, and the Middle East. While other companies have for years made promises of robotic IV automation products, and even showcased marketing demonstrations of competing solutions that were supposed to exist as far back as ten years ago, the fact remains that CytoCare(TM) is the only available solution that currently exists anywhere in the world to automatically compound and prepare ready-to-administer hazardous and non-hazardous IV Admixtures, and that has been proven in a "live" hospital pharmacy environment.

"Over the past year Health Robotics has significantly added to its already impressive leadership position in the sector of IV Admixtures Automation. The company has solidified its partnership with B|Braun in some European and Asia-Pacific countries; additionally, very positive dividends are beginning to emerge out of the investments we and our business partners have made with CytoCare(TM) in North America, Middle East and Japan; and lastly, the company has received an unprecedented positive response to the announcement of its non-hazardous IV medications solution IV Station(TM). We are very pleased to be working with such serious partners as AHCSC-OLAYAN. They join a growing list of prestigious health care providers that have adopted our robotic solutions", stated Werner Rainer, CEO of Health Robotics.

"From a customer adoption perspective I would like to share that in the two years since we started this journey, we have installed more IV robots than all of our competitors have sold in over ten years of operations, and we have received purchase orders for one thousand more robots than all of our competitors combined. We are very pleased to see great progress in the hospitals' reception for CytoCare(TM) in new countries such as Germany, Australia, Japan, Taiwan, France, Belgium, Czech Republic, Saudi Arabia, United Arab Emirates, Slovakia, Austria, and also in the United States. I am also pleased to share that extensive tests with thousands of IV doses conducted by the University of Colorado in Denver, Rigshospitalet at the University of Copenhagen, and at Charing Cross NHS Trust in London have proven CytoCare(TM) features preventing cross-contamination and delivering sterile and extremely accurate ready-to-administer hazardous and non-hazardous IV Admixtures in the real-world hospital pharmacy environment, as opposed to our competitors who are still making ten-year old claims of studies done by themselves at their manufacturing facilities with no independent verification of such tests at any hospital pharmacy in the world," concluded Werner Rainer, CEO of Health Robotics.

About Health Robotics:

Health Robotics is the global leading supplier in the automation of life-critical intra-venous patient-specific medication preparation, compounding, and dispensing, providing health care facilities around the world with robotics and software automation solutions. The world-leading solutions CytoCare(TM) and IV Station(TM) have and will greatly contribute to ease global pharmacies' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to decrease life-threatening medication errors and cross-contamination risks, and to work more efficiently, increase throughput, reduce IV waste, and contain spiralling costs.

About AHCSC-Olayan:

Arabian Health Care Supply Company (AHCSC), founded in Riyadh in 1979, occupies a leading position in the GCC medical business market as a distributor of a wide array of medical and pharmaceutical products from many of the biggest names in the industry, including Baxter, Edwards Lifesciences, Kimberly-Clark, Cardinal Health (Pyxis), Orthofix, Armstrong Healthcare, Sterilox and Cyberonics. To ensure that patients receive the best possible service, AHCSC provides educational and training programs for doctors, pharmacists, and nurses. With a team of 90 skilled and dedicated professionals, AHCSC is committed to setting the highest standard for customer service, value and product quality for its customers.

For additional information, please contact:

Health Robotics

Gaspar G. DeViedma

In Europe: +39(346)963-4934

In America: +1(609)980-7976

Arabian Healthcare Supply Corporation

Nabeel Al-Aswad

In Saudi Arabia: +966-555118074

SOURCE Health Robotics SRL
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
(Date:11/25/2015)... November 26, 2015 ... Market 2016 - 2020 report analyzes that automating ... and quality in long-term samples, minimizing manual errors, ... Automation minimizes manual errors such as mislabeling or ... Further, it plays a vital role in blood ...
(Date:11/25/2015)... Studies reveal the differences in ... pave the way for more effective treatment for one of ...   --> --> Gum ... in cats, yet relatively little was understood about the bacteria ... been conducted by researchers from the WALTHAM Centre for Pet ...
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
Breaking Biology Technology:
(Date:11/19/2015)... 2015  Although some 350 companies are actively involved ... few companies, according to Kalorama Information. These include Roche Diagnostics, ... market share of the 6.1 billion-dollar molecular testing market, ... for Molecular Diagnostic s .    ... controlled by one company and only a handful of ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
Breaking Biology News(10 mins):